FDA and NIH let clinical trial sponsors keep results secret and break the law

For 20 years, the U.S. government has urged companies, universities, and other institutions that conduct clinical trials to record their results in a federal database, so doctors and patients can see whether new treatments are safe and effective. Few trial sponsors have consistently done so, even after a 2007 law made posting mandatory for many trials registered in the database. More

What Is The Status Of Research On Low-Value Care?

Millions of Americans are receiving medical treatments, tests, and procedures that are either wasteful or ineffective every single year. These services, dubbed as “low-value health care,” are defined as services for which the potential for harm outweighs the potential for benefit, and they have critical consequences for patients and the health system at large, as they are estimated to cost $300 billion nationally each year. More

Black Scientists Held Back by Perceptions of Their Priorities

Eight years ago, a study published in Science found that black researchers were 10 percentage points less likely than white ones to receive funding from the National Institutes of Health, even after controlling for factors like educational background, previous research awards and publication record. Its authors theorized that the difference might reflect an accumulation of slight advantages over the course of white scientists’ careers. That study, which the N.I.H. itself commissioned, prompted the agency to put $500 million toward a 10-year initiative to improve the situation, for example by increased mentoring of minority researchers and efforts to address possible bias in peer review. But new research suggests racial disparity in grant funding persists, and offers a fresh theory about a source of some of it: research topic choice.